Brown Brothers Harriman & CO Jazz Pharmaceuticals PLC Transaction History

Brown Brothers Harriman & CO

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	BUY	$129.64 - $160.7 $84,265 - $104,454	650 New	650 $101,000
Q4 2021 Feb 14, 2022	SELL	$119.87 - $145.67 $958 - $1,165	-8 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$128.64 - $184.79 $514 - $739	-4 Reduced 33.33%	8 $1,000
Q2 2021 Aug 13, 2021	BUY	$160.2 - $186.42 $1,281 - $1,491	8 Added 200.0%	12 $2,000
Q1 2021 May 13, 2021	SELL	$150.19 - $173.5 $297,075 - $343,183	-1,978 Reduced 99.8%	4 $1,000
Q4 2020 Feb 16, 2021	BUY	$140.71 - $165.05 $24,764 - $29,048	176 Added 9.75%	1,982 $327,000
Q3 2020 Nov 16, 2020	SELL	$105.46 - $144.13 $38,176 - $52,175	-362 Reduced 16.7%	1,806 $258,000
Q2 2020 Aug 13, 2020	BUY	$95.68 - $121.88 $204,563 - $260,579	2,138 Added 7126.67%	2,168 $239,000
Q1 2020 May 15, 2020	BUY	$87.74 - $152.74 $2,632 - $4,582	30 New	30 $3,000
Q4 2019 Feb 14, 2020	SELL	$117.65 - $153.73 $588 - $768	-5 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$125.55 - $144.48 $627 - $722	5 New	5 $1,000
Q1 2018 May 14, 2018	SELL	$135.59 - $157.16 $6,101 - $7,072	-45 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$131.06 - $150.39 $5,897 - $6,767	45	45 $6,000

512

57.5M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Brown Brothers Harriman & CO, based on Form 13F filings with the SEC.

Stay updated on Brown Brothers Harriman & CO with notifications on news.